The effect of fluorination of zinc oxide nanoparticles on evaluation of their biodistribution after oral administration

Monitoring of the behavior of metal nanoparticles in the body following exposure is very important for investigation of the physiological fates and safety of these nanoparticles. In this study, we investigated the behavior and accumulation of nano-scaled ZnO (20 nm) and submicro-scaled ZnO (100 nm) particles in organic tissues after oral administration using PET imaging. Both types of ZnO nanoparticle (20 or 100 nm) were labeled with the radionuclide (18)F in high yield via 'click reaction'. (18)F labeling on the ZnO nanoparticles was maintained stably in simulated gastric fluid (pH 1.2) for 7 h. PET images indicated that (18)F and (18)F-ethoxy azide showed radioactivity in the bone and bladder 3 h after oral administration, whereas radioactivity for (18)F-labeled ZnO nanoparticles was seen only in the gastrointestinal (GI) tract. At 5 h post-administration, biodistribution studies demonstrate that (18)F accumulated in the bone (10.19 ± 1.1%ID g(-1)) and (18)F-ethoxy azide showed radioactivity in the bone (7.55 ± 0.6%ID g(-1)), liver, and brain (0.94 ± 0.3%ID g(-1)). Unlike (18)F and (18)F-ethoxy azide, (18)F-labeled ZnO nanoparticles showed radioactivity in the lung, liver and kidney including the GI tract. Submicro-scaled (18)F-labeled ZnO nanoparticles (100 nm) showed stronger radioactivity in the liver and kidney compared to nano-scaled (18)F-labeled ZnO nanoparticles (20 nm). In conclusion, PET imaging has the potential to monitor and evaluate the behavior of ZnO nanoparticles absorbed in organic tissues following oral exposures.

[1]  Maxine J McCall,et al.  Zinc oxide nanoparticles in modern sunscreens: An analysis of potential exposure and hazard , 2010, Nanotoxicology.

[2]  J. Loo,et al.  Cytotoxicity of zinc oxide (ZnO) nanoparticles is influenced by cell density and culture format , 2011, Archives of Toxicology.

[3]  Ick Chan Kwon,et al.  Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models. , 2011, Biomaterials.

[4]  C. van Nostrum,et al.  Synthesis and applications of biomedical and pharmaceutical polymers via click chemistry methodologies. , 2009, Bioconjugate chemistry.

[5]  Dong Wang,et al.  Click Chemistry, A Powerful Tool for Pharmaceutical Sciences , 2008, Pharmaceutical Research.

[6]  Dong Wook Kim,et al.  Oleyl-chitosan nanoparticles based on a dual probe for optical/MR imaging in vivo. , 2011, Bioconjugate chemistry.

[7]  In-Kyu Park,et al.  Superparamagnetic iron oxide nanoparticles as a dual imaging probe for targeting hepatocytes in vivo , 2009, Magnetic resonance in medicine.

[8]  Sophie Lanone,et al.  Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. , 2006, Current molecular medicine.

[9]  Peter Wick,et al.  Nanotoxicology: an interdisciplinary challenge. , 2011, Angewandte Chemie.

[10]  Washington Sanchez,et al.  Imaging of zinc oxide nanoparticle penetration in human skin in vitro and in vivo. , 2008, Journal of biomedical optics.

[11]  H. Santos,et al.  ¹⁸F-labeled modified porous silicon particles for investigation of drug delivery carrier distribution in vivo with positron emission tomography. , 2011, Molecular pharmaceutics.

[12]  Meng Wang,et al.  Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice. , 2006, Toxicology letters.

[13]  J. Li,et al.  Determination, characterization and cytotoxicity on HELF cells of ZnO nanoparticles. , 2010, Colloids and surfaces. B, Biointerfaces.

[14]  Hyun-chul Lee,et al.  Radioevaluation of PAMs, CMs, and PS‐Lip as an oral carrier for vaccine delivery into intestinal Peyer's patches , 2006 .

[15]  Thomas R. Tice,et al.  Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches , 1990 .

[16]  Hiroyuki Ohshima,et al.  In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.

[17]  M. Glaser,et al.  "Click labeling" with 2-[18f]fluoroethylazide for positron emission tomography. , 2007, Bioconjugate chemistry.

[18]  Chenjie Xu,et al.  PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles , 2008, Journal of Nuclear Medicine.

[19]  A. Florence,et al.  Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency , 1990, The Journal of pharmacy and pharmacology.

[20]  Kyunghee Choi,et al.  Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. , 2010, Environmental toxicology and pharmacology.

[21]  Zinc oxide particles induce inflammatory responses in vascular endothelial cells via NF-κB signaling. , 2010, Journal of hazardous materials.

[22]  Bob Jin Kwon,et al.  Synthesis and characterization of 3-[131I]iodo-L-tyrosine grafted Fe3O4@SiO2 nanocomposite for single photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI). , 2011, Journal of nanoscience and nanotechnology.

[23]  Xiu Shen,et al.  Size-dependent in vivo toxicity of PEG-coated gold nanoparticles , 2011, International journal of nanomedicine.